CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-19 | AMGEN INC 10% owner | Conversion | +33,603,948 | 33,603,948 | ||
| 2023-09-19 | AMGEN INC 10% owner | Purchase | +1,764,705 | $17.00 | $30.0M | 35,368,653 |
| 2023-09-19 | AMGEN INC 10% owner | Conversion · Series A-2 Preferred Stock | −32,754,291 | 0 | ||
| 2023-09-19 | AMGEN INC 10% owner | Conversion · Series B Preferred Stock | −849,657 | 0 |
Page 1 of 1 · 4 trades